Reply to: “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”

Nalee Kim; Jinsil Seong

doi:10.1016/j.jhep.2020.04.016

Reply to: “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”

Nalee Kim
, Jinsil Seong

Yonsei University

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	468-469
Number of pages	2
Journal	Journal of Hepatology
Volume	73
Issue number	2
DOIs	https://doi.org/10.1016/j.jhep.2020.04.016
State	Published - Aug 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jhep.2020.04.016

Cite this

@article{e35f7065f8d44790bef3395564f311c2,

title = "Reply to: “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”",

author = "Nalee Kim and Jinsil Seong",

year = "2020",

month = aug,

doi = "10.1016/j.jhep.2020.04.016",

language = "English",

volume = "73",

pages = "468--469",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Reply to

T2 - “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”

AU - Kim, Nalee

AU - Seong, Jinsil

PY - 2020/8

Y1 - 2020/8

UR - https://www.scopus.com/pages/publications/85086372573

U2 - 10.1016/j.jhep.2020.04.016

DO - 10.1016/j.jhep.2020.04.016

M3 - Letter

C2 - 32467075

AN - SCOPUS:85086372573

SN - 0168-8278

VL - 73

SP - 468

EP - 469

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 2

ER -

Reply to: “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”

UN SDGs

Access to Document

Other files and links

Cite this